However, the majority of patients only experience mild to moderate lethargy and recover uneventfully with only supportive care [4, 84, 85]
Data was analyzed using the independent t test
However, the growing global burden of MASLD and MASH, along with the urgent need for effective pharmacotherapies, has driven the adoption of non-histological surrogate endpoints for treatment assessment in MASH [7]
Research demonstrates that doxorubicin, a common chemotherapeutic agent, induces widespread cellular senescence in addition to its anti-cancer effects, contributing to severe off-target toxicity and long-term health complications in cancer survivors
Pre-mixed vials lock the ratio they cannot be used during the staged titration described above without overdosing one component or underdosing the other